Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...

The author faced challenges with chemotherapy, initially opting for a combination of oral and intravenous treatments before switching to oral medication only. The COVID-19 pandemic allowed the author ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient DNA mismatch repair (dMMR) colon cancer significantly improved survival in ...

An international study shows that cancer survivors who get moving after chemo can increase their chances of beating colon cancer, making exercise a game-changer for long-term survival. Study: ...

Six months of chemotherapy in low-risk stage 3 colorectal cancer patients increases neuropathy compared to three months. IDEA collaboration found similar survival outcomes between three and six months ...

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...

Real-world comparative outcomes of chemo-immunotherapy versus chemotherapy in colon cancer: A multi-center retrospective cohort study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Please provide your email address to receive an email when new articles are posted on . Patients with stage III deficient mismatch repair colon cancer derived significant benefit from the addition of ...

A 62-year-old Yishun hawker battling Stage 4 colon cancer continued to exercise and show up for work each day while ...